Sign in
ANIK Stock Price, Chart, Stats & News
Anika Therapeutics, Inc.
Save
Anika Therapeutics, Inc. (ANIK) does not currently pay a dividend.
266.92M
Market cap
40.70x
Current P/E
21.98x
Forward P/E
ANIK chart
Fundamentals
Gross margin | 56.56% |
Operating margin | -9.80% |
Pretax margin | -8.25% |
Net margin | -9.64% |
Effective tax rate | -7.22% |
ROA | -5.72% |
ROE | -7.42% |
D/E | 0.17x |
Interest coverage ratio | -93.65x |
ANIK valuation
P/E | 40.70x |
P/S | 1.83x |
P/B | 1.42x |
P/CF | 18.22x |
P/FCF | 47.21x |
P/OCF | 18.22x |
PEG | -0.28x |
EV multiple | -58.50x |
About
Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core focus areas include osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and advanced bone-preserving joint technologies. All of Anika's products are developed, manufactured, and commercialized utilizing their proprietary hyaluronic acid (HA) technology platform.
Similar securities
Based on sector and market capitalization
Report issue